실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,103+프로그램
35+FDA 승인
4,001+모집 중
ADC 1048·Antibody 5318·CGT 2737차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
476오늘 방문
1,387누적 방문
7846갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,105개
다음 갱신 D-14 · 마지막 7월 18일
ADCBiologicstaleCStone PharmaceuticalsPhase 1

CS5001 (CS5001)

Advanced Solid Tumor; Advanced Lymphoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

IFX + MTX (Infliximab + methotrexate, Infliximab + methotrexate (IFX + MTX))

Arthritis, Psoriatic · Arthritis, Psoriatic

#ArthritisPsoriatic#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab Increased Dose (Infliximab Increased Dose)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab Control (Infliximab Control)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAbbViePreclinical

adalimumab (Humira, Dovobet, neotigason, etanercept, adalimumab. infliximab)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleBolt Biotherapeutics, Inc.Phase 2

BDC-4182 (BDC-4182)

Gastric Cancer Adenocarcinoma Metastatic; Gastroesophageal Adenocarcinoma · Gastric Cancer Adenocarcinoma Metastatic

#GastricCancerAdenocarcinomaMetas#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleNovatim Immune Therapeutics (Zh…Phase 2

KY-0301 (KY-0301)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleNBE-Therapeutics AGPhase 2

NBE-002 (NBE-002)

Advanced Solid Tumor; Advanced Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleEMD Serono Research & Developme…Phase 1

M3554 (M3554)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Infliximab Increased Frequency (Infliximab Increased Frequency)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 2

Infliximab; Gemcitabine (Infliximab; Gemcitabine)

Cachexia; Pancreatic Neoplasms · Cachexia

#Cachexia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

MTX (Infliximab + methotrexate, Infliximab + methotrexate (MTX))

Arthritis, Rheumatoid · Arthritis, Rheumatoid

#ArthritisRheumatoid#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 2

REGN3500 + Dupilumab Combo (REGN3500 + Dupilumab Combo)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleAmgenPhase 2

Blinatumomab and Inotuzumab Ozogamicin (Blinatumomab and Inotuzumab Ozogamicin)

Acute Lymphoblastic Leukemia; Immunotherapy · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBigHat Biosciences, Inc.Phase 2

BHB810 (BHB810)

Gastric Cancer; Gastric Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleBayerPhase 1

BAY1129980 (Lupartumab Amadotin, Lupartumab Amadotin (BAY1129980))

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleMythic TherapeuticsPhase 1

MYTX-011 (MYTX-011)

NSCLC; NSCLC Stage IV · NSCLC

#NSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleHummingbird BiosciencePhase 2

ENV-501 (ENV-501)

Melanoma (Skin); Non Small Cell Lung Cancer · Melanoma (Skin)

#MelanomaSkin#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleJiangsu Alphamab Biopharmaceuti…Phase 2

JSKN033 (JSKN033)

Cervical Cancer · Cervical Cancer

#CervicalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleJiangsu Alphamab Biopharmaceuti…Phase 2

Platinum (Platinum)

Cervical Cancer · Cervical Cancer

#CervicalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 4.86%임상시험 1상태 RECRUITING
ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 1

an antibody drug conjugate (an antibody drug conjugate)

Neoplasms · Neoplasms

#Neoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 31.2%임상시험 1상태 ACTIVE
CGTBiologicstaleThe Affiliated Hospital of Xuzh…Phase 2

ASCT+CAR-T Cell Infusion (ASCT+CAR-T Cell Infusion)

B-cell Lymphoma · B-cell Lymphoma

#B-cellLymphoma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

ustekinumab (Stelara, 1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

ustekinumab (Stelara, 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infliximab Dose Intensification (Infliximab Dose Intensification)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING

108 / 165 페이지

← 이전다음 →
전체 9,103개 프로그램 보기